{14 (24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]) / 4 (apremilast 10 MG Oral Tablet [Otezla]) / 4 (apremilast 20 MG Oral Tablet [Otezla]) / 19 (apremilast 30 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20/30/75 Starter Pack]
RxNorm concept 2724367, branded pack (bpck). Prescribable name: Otezla 28-Day 10/20/30/75 Starter Pack.
- RxCUI
- 2724367
- Term type
- Branded pack (BPCK)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2724367 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- apremilast 10 MG Oral Tablet [Otezla] (SBD, contains)
- apremilast 20 MG Oral Tablet [Otezla] (SBD, contains)
- apremilast 30 MG Oral Tablet [Otezla] (SBD, contains)
- 24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla] (SBD, contains)
- Pack (DF, has dose form)
- {14 (24 HR apremilast 75 MG Extended Release Oral Tablet) / 4 (apremilast 10 MG Oral Tablet) / 4 (apremilast 20 MG Oral Tablet) / 19 (apremilast 30 MG Oral Tablet) } Pack (GPCK, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2724367 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2724367 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2724367. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.